TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

A loud ringing and bright light jolted Adam English awake. Then he felt the bizarre sensation of a zipper closing from ear to ...

Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne were able to get an HIV-detecting form of mRNA into cells donated by HIV patients by wrapping the mRNA in a ...

They looked for inspiration, in part, from HIV patients in South Africa whose bodies seem to naturally produce broadly neutralizing antibodies.

There is uncertainty in the literature regarding the safety and efficacy of chimeric antigen receptor T-cell (CAR-T) therapy in HIV+ patients. This study aims to evaluate the influence of HIV ...

However, patients with HIV (PWH) have historically been excluded from CAR T-cell studies. This is likely due to assumed decreased efficacy and increased infection-related morbidity and mortality due ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and a much lower cost than many existing treatments, an initial ...

Mike McCune said the Gates Foundation is “doubling down” on finding a cure for HIV during an ASGCT symposium.

Richmond nonprofit director Zakia McKensey warns that recent cuts to HIV program funding could lead to increased virus transmission as housing and food assistance for patients diminishes.